DH Enchantment, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024

DH Enchantment, Inc.

ENMI

US25241A1034

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 08:39:47 01/07/2024 pm IST			5-day change	1st Jan Change
0.0021 ^USD	+5.00%		+50.00%	-8.70%

01/07

DH Enchantment, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024

July 01, 2024 at 06:25 pm IST

DH Enchantment, Inc. reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was USD 0.000686 million compared to USD 0.015098 million a year ago. Net loss was USD 0.156153 million compared to USD 0.385877 million a year ago.

Latest news about DH Enchantment, Inc.

DH Enchantment, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024

01/07

Chart DH Enchantment, Inc.

Duration

Period

More charts

Company Profile

DH Enchantment, Inc. is a holding company. The Company conducts its operations through its Hong Kong subsidiary, Ho Shun Yi Limited (HSY). HSY is engaged primarily in the sale and distribution of Coronavirus Disease 2019 (COVID-19) rapid antigen tester sets produced by third parties. HSY primarily sells its products primarily in Hong Kong. HSY's wholly owned subsidiary is DH Investment Group Limited, which is an investment holding company. The Company operates its testing business through DH Investment Group Limited.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DH ENCHANTMENT, INC.	-8.70%	1.75M
ELI LILLY AND COMPANY	+54.07%	809B
NOVO NORDISK A/S	+38.76%	621B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	319B
ABBVIE INC.	+5.72%	289B
ASTRAZENECA PLC	+14.13%	238B
ROCHE HOLDING AG	-0.98%	221B
NOVARTIS AG	+14.40%	218B
AMGEN INC.	+7.42%	166B